Pura Vida Investments’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Pura Vida Investments’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,182,975	Closed	-$25.3M	–	194
2022 Q4	$25.3M	Buy	1,182,975 +207,545	+21%	+$4.43M	1.31%	21
2022 Q3	$17.5M	Buy	975,430 +260,286	+36%	+$3.42M	1.01%	28
2022 Q2	$6.88M	Sell	715,144 -150,000	-17%	-$1.88M	0.4%	68
2022 Q1	$14.6M	Sell	865,144 -24,310	-3%	-$359K	0.47%	53
2021 Q4	$14.9M	Buy	889,454 +857,689	+2,700%	+$14.1M	0.54%	47
2021 Q3	$516K	Sell	31,765 -16,300	-34%	-$177K	0.02%	248
2021 Q2	$303K	Buy	+48,065	New	+$310K	0.01%	206
2016 Q4	–	Sell	-42,500	Closed	-$1.96M	–	101
2016 Q3	$1.96M	Sell	42,500 -10,000	-19%	-$564K	0.6%	61
2016 Q2	$2.68M	Buy	52,500 +20,000	+62%	+$994K	1.14%	39
2016 Q1	$1.37M	Buy	+32,500	New	+$1.66M	0.62%	54

Other funds holding ISEE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Pura Vida Investments's ISEE Position: Q1 2023 in Review

Pura Vida Investments sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2023, closing a stake of 1,182,975 shares — an estimated $25.3M sold.

Pura Vida Investments first reported a position in ISEE in Q1 2016 and held it in 10 quarters. The position peaked at $25.3M in Q4 2022. 223 funds tracked by Wall St. Rank hold ISEE as of Q1 2023.

Pura Vida Investments reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Pura Vida Investments sold 1,182,975 IVERIC bio, Inc. Common Stock shares in Q1 2023, an estimated $25.3M.
Pura Vida Investments first reported a position in IVERIC bio, Inc. Common Stock in Q1 2016 and held it in 10 quarters.
Pura Vida Investments's IVERIC bio, Inc. Common Stock position peaked at $25.3M in Q4 2022.
223 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2023.

Based on Pura Vida Investments's 13F filing for Q1 2023, filed 15 May 2023.